VANCOUVER, British Columbia, June 30, 2021 (GLOBE NEWSWIRE) — EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), announced today that Mr. Morten Borch and Mr. Bobby Doyon have both resigned as members of the Board of Directors.
Mr. Borch is reducing his general business and board commitments currently. Mr. Doyon wishes to focus his time and efforts on his professional duties and commitments. Both directors were planned, and had accepted, to be vacating their board seats at the company upon the planned closing of the proposed business combination with Global Cannabinoids.
EXM and the Board are currently evaluating candidates with respect to appointing two new independent directors to fill the two current vacancies.
The Board of Directors would like to thank both Mr. Borch and Mr. Doyon for their meaningful contribution over the past few years and wish them well in all their future endeavors.
ON BEHALF OF THE BOARD OF DIRECTORS OF EXMCEUTICALS INC.
Jonathan Summers, Chairman and Chief Executive Officer
For further information, contact:
Investor Relations
Email: investors@exmceuticals.com
FOR MORE UPDATES ON THE COMPANY
Follow us on Twitter: https://twitter.com/EXMceuticals
Follow us on LinkedIn: https://www.linkedin.com/company/exmceuticalsinc/
Calls for Contributions to Support Future Medical Device & Pharmaceutical Packaging LeadersArlington, Virginia--(Newsfile Corp. -…
Calgary, Alberta--(Newsfile Corp. - December 10, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE:…
Albe brings extensive immunology and translational research experience to his full-time role working with WRF's…
BOCA RATON, Fla., Dec. 10, 2025 /PRNewswire/ -- Omega Healthcare, a leading provider of technology-driven healthcare…
Industry collaboration leads to significant improvements in CY 2026 Final Rule but long-term stability remains…
Ohio patients empowered to compare prices, save on care, fight surprise bills COLUMBUS, Ohio,, Dec. 10,…